Abstract:Ferroptosis modulation represents a pioneering therapeutic approach for non-small-cell lung cancer (NSCLC), where precise monitoring and regulation of ferroptosis levels are pivotal for achieving optimal therapeutic outcomes. Cisplatin (Cis), a widely used chemotherapy drug for NSCLC, demonstrates remarkable therapeutic efficacy, potentially through its ability to induce ferroptosis and synergize with other treatments. However, in vivo studies of ferroptosis face challenges due to the scarcity of validated biomarkers and the absence of reliable tools for real-time visualization. Biothiols emerge as suitable biomarkers for ferroptosis, as their concentrations decrease significantly during this process. To address these challenges, fluorescence/photoacoustic (PA) bimodal imaging offers a promising solution by providing more accurate in vivo information on ferroptosis. Therefore, the development of methods to detect biothiols using fluorescence/PA bimodal imaging is highly desirable for visualizing ferroptosis in NSCLC. In this study, we designed and constructed two activatable near-infrared (NIR) fluorescent/PA bimodal imaging probes specifically for visualizing ferroptosis by monitoring the fluctuations in biothiol levels. These probes exhibited excellent bimodal response performance in solution, cells, and tumors. Furthermore, they were successfully applied for real-time monitoring of biothiol changes during the ferroptosis process in NSCLC cells and tumors. Importantly, our findings revealed that the combined use of erastin and cisplatin exacerbates the consumption of biothiols, suggesting an enhancement of ferroptosis in NSCLC. This work not only provides powerful tools for monitoring in vivo ferroptosis but also facilitates the study of ferroptosis mechanisms and holds the potential to further advance the treatment of NSCLC.

In Situ and Quantitatively Monitoring the Dynamic Process of Ferroptosis in Single Cancer Cells by Scanning Electrochemical Microscopy

Targeting Ferroptosis in Breast Cancer

Ferroptosis Detection: From Approaches to Applications

Recent advances in small-molecule fluorescent probes for studying ferroptosis

Recent Progress in Ferroptosis Inducers for Cancer Therapy

Microenvironment‐differential Imaging of Demethylated Metabolites of Methionine for Identifying Ferroptosis Regional Preferences with Path‐independent Equifinal Fluorescence Probes

Modulating ferroptosis sensitivity: environmental and cellular targets within the tumor microenvironment

Illuminating Cisplatin-induced Ferroptosis in Non-Small-Cell Lung Cancer with Biothiols-Activable Fluorescent/ Photoacoustic Bimodal Probes

Illuminating cisplatin-induced ferroptosis in non-small-cell lung cancer with biothiol-activatable fluorescent/photoacoustic bimodal probes

Emerging mechanisms and targeted therapy of ferroptosis in cancer

Ferroptosis in Cancer Treatment: Another Way to Rome

Mechanosensitive fluorescence lifetime probes for investigating the dynamic mechanism of ferroptosis

Endogenous molecule-targeted fluorescent probes for ferroptosis visualization: Current progress and future prospects

Advances in ferroptosis of cancer therapy

Fluorescent probes for ferroptosis bioimaging: advances, challenges, and prospects

Ferroptosis: a new mechanism of traditional Chinese medicine for cancer treatment

Molecular mechanisms of ferroptosis and its role in cancer therapy

Recent progress in nanotechnology based ferroptotic therapies for clinical applications

The mechanisms and therapeutic targets of ferroptosis in cancer

Ferrous-Supply-Regeneration Nanoengineering for Cancer-Cell-Specific Ferroptosis in Combination with Imaging-Guided Photodynamic Therapy.

Recent Advances of Fluorescence Probes for Imaging of Ferroptosis Process